|
Symbol
|
KSADDU | RMAEHV | OBORCH | RMAZ7V | AACXTQ | RMAFFV | BZIBKB | RMA93V | RMBA5V | OOWRCH | OPRRCH | CBRBKB | RMBAQV | AAPGTQ | KYPQDU | AASJTQ | RMA72V | OSDRCH | RMBH1V | RMAPBV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Worst of Reverse Convertible | Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti |
|
Basiswert
|
Sandoz Group AG / Sonova Hldg. AG / Straumann Hldg. AG | Alcon / Novartis AG / Sandoz | Roche PS / Sandoz Group AG / Straumann Hldg. AG | Alcon / Lonza Group N / Novartis AG / Sandoz Group AG | Alcon / Sandoz Group AG / Straumann Hldg. AG | Alcon / Galderma Group AG / Sandoz Group AG | Alcon / Novartis AG / Sandoz | Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Alcon / Sandoz Group AG / Straumann Hldg. AG | Novartis AG / Roche PS / Sandoz Group AG / Swisscom N / Zurich Insurance Group AG | Alcon / Sandoz Group AG / Straumann Hldg. AG | Nestlé S.A. / Novartis AG / Roche PS / Sandoz Group AG / Straumann Hldg. AG | Clariant AG / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Adecco Group AG / Sandoz Group AG / Sika AG | Alcon / Sandoz Group AG / Sonova Hldg. AG / Straumann Hldg. AG | Novartis AG / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | Lonza Group N / Sandoz Group AG / Sonova Hldg. AG / Straumann Hldg. AG | Lonza Group N / Nestlé S.A. / Novartis AG / Roche PS / Sandoz Group AG | Alcon / Novartis AG / Sandoz |
|
Emittent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälligkeit
|
17.04.2026 | 20.04.2026 | 22.04.2026 | 15.06.2026 | 17.06.2026 | 29.06.2026 | 08.07.2026 | 12.01.2027 | 05.01.2027 | 22.04.2026 | 26.01.2027 | 02.11.2026 | 09.02.2027 | 12.08.2026 | 21.08.2026 | 26.08.2026 | 31.08.2026 | 19.08.2026 | 25.09.2026 | 07.09.2026 |
| Geld | - | - | - | 99.70 | 99.41 | 95.40 | 98.50 | 96.70 | 96.90 | - | 99.87 | 92.18 | 93.00 | 66.77 | 60.35 | 82.95 | 72.80 | 92.29 | 99.10 | 89.60 |
| Brief | - | - | - | 100.90 | - | 96.60 | - | 97.90 | 98.10 | - | 100.67 | - | 94.20 | - | 61.35 | - | - | - | 100.30 | 91.10 |